Giovanni Caforio

M.D.(7) Executive Chair and Former Chief Executive OfficeratBristol Myers Squibb· In proxies 2021–2023

Pay in FY2023-2% from the year before

Giovanni Caforio was paid $19.7M in FY2023 (Dec), down 2%.

PayNo stock prices for these years

Pay is from the Summary Compensation Table of each Bristol Myers Squibb proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Bristol Myers SquibbPublic company · 5 yr
- M.D.(7) Executive Chair and Former Chief Executive Officer2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?